Fairfield Financial Advisors »

Vertex Pharmaceuticals Incorporated shares owned by Fairfield Financial Advisors

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Fairfield Financial Advisors from 13F filings

Historical chart of Fairfield Financial Advisors investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Fairfield Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Fairfield Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $176k 376 468.72

More positions owned by Fairfield Financial Advisors

Auto Data Processing Common Stock (ADP)
Invsc Qqq Trust Srs 1 Etf Iv Uit Exchange Traded (QQQ)
Technology Select Sectorspdr Etf Uit Exchange Traded (XLK)
Jensen Quality Growth I Equity Funds (JENIX)
Parnassus Core Equity Investor Ntf Equity Funds (PRBLX)
T. Rowe Price Capital Appreciation I Ntf Equity Funds (TRAIX)
Vanguard Dividend Growth Fund Inv Equity Funds (VDIGX)
Eli Lilly And Common Stock (LLY)
Apple Common Stock (AAPL)
Alphabet Inc. Class A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Berkshire Hathaway Class B Common Stock (BRK.B)
Novo-nordisk As Vormal Fsponsored Adr 1 Adr Reps 1 Ord American Depository (NVO)
Schwab Value Advantage Money Investor Sh Schwab Non-sweep Mmf (SWVXX)

View all positions for Fairfield Financial Advisors

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Capital Research Global Investors
Jennison Associates
Wellington Management Company
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services

View all funds holding Vertex Pharmaceuticals Incorporated